Sarpagandha
Rauvolfia serpentina (L.) Benth. ex Kurz
Sarpagandha (Rauvolfia serpentina (L.) Benth. ex Kurz) is a plant drug, also called Candrika, Chandramarah and Nakuli, from the Apocynaceae family. CITES Appendix II (trade regulation for conservation); IUCN Endangered status; WHO acknowledges traditional antihypertensive use; reserpine is on WHO Model List of Essential Medicines.
| Botanical name | Rauvolfia serpentina (L.) Benth. ex Kurz |
|---|---|
| Family | Apocynaceae · other entries in this family |
| Order | Gentianales |
| Pharmacopoeia status | CITES Appendix II (trade regulation for conservation); IUCN Endangered status; WHO acknowledges traditional antihypertensive use; reserpine is on WHO Model List of Essential Medicines |
| Taxon identifiers | GBIF 3169787 · Wikidata Q1145301 · NCBI Taxonomy 4060 |
| Sanskrit | चन्द्रिका (candrikā), Chandramarah, नाकुली (nākulī) |
|---|---|
| Hindi | सर्पगंधा (sarpagaṃdhā), Chhotaa Chaand, छोटा चांद (choṭā cāṃda), Dhavalbaruaa, सर्पगन्धा (sarpagandhā) |
| English | Rauvolfia Root, Serpentina Root |
| Tamil | சர்பகந்தி, Sarppaganti |
| Malayalam | Amalpori |
| Telugu | Sarpagandhi |
| Kannada | Sutranaabhu |
| Marathi | Adkai, Chandra |
| Bengali | Chaandar |
| Gujarati | Amelpodee |
| Oriya | Dhanbarua, Sanochado |
Sources: Ayurvedic Pharmacopoeia of India; Ayurvedic Pharmacopoeia of India Part I, SARPAGANDHA (Root) = Rauwolfia serpentina, Tamil: 'Sarppaganti'.; Same attestation as सर्पगंधा: eFloraofIndia, Rauvolfia serpentina, Hindi सर्पगंधा; API monograph title SARPAGANDHA for this species.; eFloraofIndia / Names of Plants in India, Rauvolfia serpentina, Hindi: चन्द्रभाग, छोटा चांद, नाकुली, सर्पगंधा. Corroborated by API Part I, SARPAGANDHA (Root) = Rauwolfia serpentina (Linn.) Benth. ex Kurz, whose Tamil is 'Sarppaganti' and Telugu 'Sarpagandhi'.; eFloraofIndia / Names of Plants in India, Rauvolfia serpentina, Hindi: चन्द्रभाग, छोटा चांद, नाकुली, सर्पगंधा. Corroborated by API SARPAGANDHA Hindi 'Chhotaa Chaand, Dhavalbaruaa'; eFloraofIndia / Names of Plants in India, Rauvolfia serpentina, Sanskrit: चन्द्रिका, नाकुली, पातालगरुड, सर्पगंधा. Corroborated by API SARPAGANDHA Sanskrit 'Nakuli, Candrika, Chandramarah'; eFloraofIndia, Rauvolfia serpentina, Sanskrit: चन्द्रिका; API SARPAGANDHA Sanskrit 'Candrika'. How we source.
The evidence at a glance
11papers on this site for this drug, published 2002 to 2025, every one with a DOI.
- 3Other clinical studies and reviews
- 8Laboratory and animal studies
A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.
Names and identification
| Language | Name |
|---|---|
| English | Sarpagandha |
| Latin/Botanical | Rauvolfia serpentina (L.) Benth. ex Kurz |
Key Phytochemical Constituents
- Reserpine
- Ajmaline
- Ajmalicine (raubasine)
- Serpentine
- Yohimbine
- Rescinnamine
- Deserpidine
- Serpentinine
How does it work?
- Antihypertensive: Reserpine irreversibly inhibits vesicular monoamine transporter 2 (VMAT2), depleting catecholamine (norepinephrine, dopamine) stores in sympathetic nerve terminals, reducing peripheral vascular resistance
- Sedative/Antipsychotic: Central depletion of monoamines (dopamine, serotonin, norepinephrine) produces tranquilizing effect; historically used before synthetic antipsychotics
- Anti-arrhythmic: Ajmaline blocks sodium channels (Class Ia antiarrhythmic), prolonging cardiac action potential and effective refractory period
Which traditional uses are supported by research?
These summaries come from the source notes, which do not name the studies behind them.
- Raktachapa-hara (antihypertensive): traditionally used to lower blood pressure. Reserpine was one of the first antihypertensive drugs used in Western medicine.
- Nidrajanana (sedative): traditionally used as a sedative and anxiolytic. A mechanism involving VMAT2 inhibition and central monoamine depletion has been described.
- Anti-arrhythmic use: traditionally used for irregular heart rhythm. Ajmaline is still used clinically in the Ajmaline test, a diagnostic test for Brugada syndrome.
What do recent studies show?
No study for this section could be traced to a published paper. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Serious adverse effects at high doses: depression (from central monoamine depletion), severe hypotension, bradycardia, nasal congestion, and sedation; contraindicated in patients with history of depression
- Contraindicated during pregnancy (may cause neonatal respiratory depression); interactions with MAO inhibitors, barbiturates, and other CNS depressants; requires close medical supervision
What is it made of?
Key Active Markers
- Ajmalicine
- Reserpine
- Ajmaline
- Serpentine
- Yohimbine
- Rescinnamine
- Deserpidine
- Serpentinine
Dosage forms and preparation
Dosage Forms: Vati (tablet), Churna (powder), Capsule, Tincture (mother tincture), Ghana vati (solid extract tablet), Sustained-release tablet
Standard Dosage: 250-500 mg root powder per day. Must be used under medical supervision due to potent hypotensive action.
Optimal Timing: Evening/bedtime dosing preferred for antihypertensive use; always with food to reduce GI side effects
Storage: Store below 25 deg C in airtight, light-protected containers. Reserpine is photolabile, amber glass or aluminum blister packaging mandatory. Controlled substance storage may apply per local regulations.
Marker Compounds: Reserpine, Ajmaline, Ajmalicine (raubasine), Serpentine, Yohimbine, Deserpidine
Synergistic Combinations
- Jatamansi (traditionally combined for calming support)
- Shankhpushpi (traditionally combined for calming support)
- Brahmi (cognitive support with anti-anxiety action)
- Arjuna (comprehensive cardiovascular formulation)
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Other clinical studies and reviews3
- 2019. Biotechnological interventions on the genus Rauvolfia: recent trends and imminent prospectsApplied microbiology and biotechnology. PMID 31363825 · doi:10.1007/s00253-019-10035-6
- 2018. Ethnopharmacology, phytochemistry, and biotechnological advances of family Apocynaceae: A reviewPhytotherapy research : PTR. PMID 29575195 · doi:10.1002/ptr.6066
- 2016. Sarpagan-Ajmalan-Type Indoles: Biosynthesis, Structural Biology, and Chemo-Enzymatic SignificanceThe Alkaloids. Chemistry and biology. PMID 26827882 · doi:10.1016/bs.alkal.2015.10.001
Laboratory and animal studies8
- 2025. Alkaloid Composition and Antiarrhythmic Activity of the Extracts from Rauvolfia serpentina Tissue CulturePlanta medica. PMID 40633549 · doi:10.1055/a-2629-0226
- 2025. Anthropogenic Disturbances and Invasion of Mikania micrantha Threaten Rauvolfia serpentina Populations in NepalEcology and evolution. PMID 41438954 · doi:10.1002/ece3.72731
- 2024. De novo biosynthesis of antiarrhythmic alkaloid ajmalineNature communications. PMID 38212296 · doi:10.1038/s41467-024-44797-z
- 2024. Proxy-approach in understanding the bisubstrate activity of strictosidine synthasesInternational journal of biological macromolecules. PMID 38354931 · doi:10.1016/j.ijbiomac.2024.130091
- 2022. Formulation and Process Optimization of Rauvolfia serpentina Nanosuspension by HPMC and In Vitro Evaluation of ACE Inhibitory PotentialJournal of functional biomaterials. PMID 36547528 · doi:10.3390/jfb13040268
- 2018. Cardioprotective and Metabolomic Profiling of Selected Medicinal Plants against Oxidative StressOxidative medicine and cellular longevity. PMID 29576858 · doi:10.1155/2018/9819360
- 2016. Transcriptome-wide identification of Rauvolfia serpentina microRNAs and prediction of their potential targetsComputational biology and chemistry. PMID 26815768 · doi:10.1016/j.compbiolchem.2015.12.002
- 2002. Anhydronium bases from Rauvolfia serpentinaPhytochemistry. PMID 12423893 · doi:10.1016/s0031-9422(02)00372-2
Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.